Ausgabe 3/2016
Inhalt (18 Artikel)
Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery
Monika Brzezinska, Linda J. Williams, Jeremy Thomas, J. Michael Dixon
Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care
Rossella Graffeo, Luca Livraghi, Olivia Pagani, Aron Goldhirsch, Ann H. Partridge, Judy E. Garber
Circulating tumor cells in breast cancer: applications in personalized medicine
Jin Sun Lee, Mark Jesus M. Magbanua, John W. Park
Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trials
Fausto Petrelli, Sandro Barni, Giacomo Bregni, Filippo de Braud, Serena Di Cosimo
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
András Lánczky, Ádám Nagy, Giulia Bottai, Gyöngyi Munkácsy, András Szabó, Libero Santarpia, Balázs Győrffy
Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family
Ciyu Yang, Angela G. Arnold, Magan Trottier, Yukio Sonoda, Nadeem R. Abu-Rustum, Oliver Zivanovic, Mark E. Robson, Zsofia K. Stadler, Michael F. Walsh, David M. Hyman, Kenneth Offit, Liying Zhang
Transcriptome- and proteome-oriented identification of dysregulated eIF4G, STAT3, and Hippo pathways altered by PIK3CA H1047R in HER2/ER-positive breast cancer
Feixiong Cheng, Junfei Zhao, Ariella B. Hanker, Monica Red Brewer, Carlos L. Arteaga, Zhongming Zhao
Assessment of pathologic response and long-term outcome in locally advanced breast cancers after neoadjuvant chemotherapy: comparison of pathologic classification systems
Misun Choi, Yeon Hee Park, Jin Seok Ahn, Young-Hyuck Im, Seok Jin Nam, Soo Youn Cho, Eun Yoon Cho
Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade
A. Hennigs, F. Riedel, F. Marmé, P. Sinn, K. Lindel, A. Gondos, K. Smetanay, M. Golatta, C. Sohn, F. Schuetz, J. Heil, A. Schneeweiss
Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study
M. E. Cazzaniga, L. Cortesi, A. Ferzi, L. Scaltriti, F. Cicchiello, M. Ciccarese, S. Della Torre, F. Villa, M. Giordano, C. Verusio, M. Nicolini, A. R. Gambaro, L. Zanlorenzi, E. Biraghi, L. Legramandi, E. Rulli, Francesca Riva, Pelizzoni Davide, Isabella Marchi, Elena Collovà, Giuseppe Prati, Antonio Ardizzoia, Davide Toniolo, Palma Pugliese, Claudia Pogliani, Abbondanza Gambino, Lucia Stocchi, Andrea Colombo, Cinzia Fasola, Raffaele Venezia, Fabio Galli, Valter Torri
Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients
M. C. van Maaren, L. de Munck, J. J. Jobsen, P. Poortmans, G. H. de Bock, S. Siesling, L. J. A. Strobbe
Internal mammary node adenopathy on breast MRI and PET/CT for initial staging in patients with operable breast cancer: prevalence and associated factors
Hyejin Cheon, Hye Jung Kim, Sang-Woo Lee, Do-Hoon Kim, Chang-Hee Lee, Seung Hyun Cho, Kyung Min Shin, So Mi Lee, Gab Chul Kim, Won Hwa Kim
Investigation of breast cancer sub-populations in black and white women in South Africa
Caroline Dickens, Ruth M. Pfeiffer, William F. Anderson, Raquel Duarte, Patricia Kellett, Joachim Schüz, Danuta Kielkowski, Valerie A. McCormack
Use of complementary and alternative medicine and breast cancer survival in the Health, Eating, Activity, and Lifestyle Study
Marian L. Neuhouser, Ashley Wilder Smith, Stephanie M. George, James T. Gibson, Kathy B. Baumgartner, Richard Baumgartner, Catherine Duggan, Leslie Bernstein, Anne McTiernan, Rachel Ballard
Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk
Mara A. Schonberg, Vicky W. Li, A. Heather Eliassen, Roger B. Davis, Andrea Z. LaCroix, Ellen P. McCarthy, Bernard A. Rosner, Rowan T. Chlebowski, Susan E. Hankinson, Edward R. Marcantonio, Long H. Ngo
Comparing treatment and outcomes of ductal carcinoma in situ among women in Missouri by race
Chinwe C. Madubata, Ying Liu, Melody S. Goodman, Shumei Yun, Jennifer Yu, Min Lian, Graham A. Colditz
Erratum to: Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient
Thomas M. Churilla, Brian L. Egleston, Colin T. Murphy, Elin R. Sigurdson, Shelly B. Hayes, Lori J. Goldstein, Richard J. Bleicher